Real-time enrollment status for this oxaliplatin induced peripheral neuropathy in cancer patients clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 3:28 AM UTC
| NCT Number | NCT07167446 |
| Recruiting Status | Recruiting |
| Condition | Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fox Chase Cancer Center |
| Last Updated on CT.gov | October 22, 2025 (Oct 22, 2025) |
As of July 18, 2026: Clinical trial NCT07167446 is currently recruiting participants. This early_phase1 study for oxaliplatin induced peripheral neuropathy in cancer patients is actively seeking new participants at 1 location across the United States. The study is sponsored by Fox Chase Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07167446 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07167446 was last updated Oct 22, 2025 (October 22, 2025). HelloStudys verifies this status automatically.